US Stock MarketDetailed Quotes

CNTX Context Therapeutics

Watchlist
  • 0.9401
  • +0.0001+0.01%
Close Apr 28 16:00 ET
84.33MMarket Cap-2.04P/E (TTM)

Context Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
19.35%29.92M
-37.83%4.31M
202.59%18.7M
-41.64%3.09M
-42.65%3.82M
68.49%25.07M
78.58%6.93M
52.68%6.18M
50.87%5.29M
93.63%6.67M
Selling and administrative expenses
-0.92%7.22M
9.85%1.79M
10.67%1.88M
-6.96%1.7M
-13.21%1.85M
-6.42%7.29M
-6.11%1.63M
-13.97%1.7M
-7.99%1.83M
1.93%2.13M
-General and administrative expense
-0.92%7.22M
9.85%1.79M
10.67%1.88M
-6.96%1.7M
-13.21%1.85M
-6.42%7.29M
-6.11%1.63M
-13.97%1.7M
-7.99%1.83M
1.93%2.13M
Research and development costs
27.66%22.7M
-52.50%2.52M
275.13%16.83M
-59.99%1.38M
-56.49%1.97M
150.77%17.78M
147.19%5.3M
115.89%4.49M
128.11%3.46M
235.53%4.53M
Operating profit
-19.35%-29.92M
37.83%-4.31M
-202.59%-18.7M
41.64%-3.09M
42.65%-3.82M
-68.49%-25.07M
-78.58%-6.93M
-52.68%-6.18M
-50.87%-5.29M
-93.63%-6.67M
Net non-operating interest income expense
174.94%3.2M
329.00%964.04K
328.21%1.24M
186.47%840.15K
-57.15%152.35K
112.69%1.16M
-31.46%224.72K
51.08%290.44K
1,277.13%293.27K
5,963.13%355.54K
Non-operating interest income
174.94%3.2M
329.00%964.04K
328.21%1.24M
186.47%840.15K
-57.15%152.35K
112.69%1.16M
-31.46%224.72K
51.08%290.44K
1,277.13%293.27K
5,963.13%355.54K
Other net income (expense)
97.43%-1.43K
105.66%3.48K
-114.00%-2.15K
50.05%-6.11K
24.74%3.35K
88.93%-55.57K
-2,568.41%-61.4K
903.20%15.37K
97.55%-12.23K
316.95%2.69K
Other non- operating income (expenses)
97.43%-1.43K
105.66%3.48K
-114.00%-2.15K
50.05%-6.11K
24.74%3.35K
-2,672.95%-55.57K
-2,568.41%-61.4K
903.20%15.37K
-305,775.00%-12.23K
316.95%2.69K
Income before tax
-11.52%-26.73M
50.62%-3.34M
-197.21%-17.46M
55.01%-2.25M
41.86%-3.67M
-61.53%-23.96M
-90.34%-6.77M
-52.42%-5.87M
-25.71%-5.01M
-83.47%-6.31M
Income tax
Net income
-11.52%-26.73M
50.62%-3.34M
-197.21%-17.46M
55.01%-2.25M
41.86%-3.67M
-61.53%-23.96M
-90.34%-6.77M
-52.42%-5.87M
-25.71%-5.01M
-83.47%-6.31M
Net income continuous Operations
-11.52%-26.73M
50.62%-3.34M
-197.21%-17.46M
55.01%-2.25M
41.86%-3.67M
-61.53%-23.96M
-90.34%-6.77M
-52.42%-5.87M
-25.71%-5.01M
-83.47%-6.31M
Minority interest income
Net income attributable to the parent company
-11.52%-26.73M
50.62%-3.34M
-197.21%-17.46M
55.01%-2.25M
41.86%-3.67M
-61.53%-23.96M
-90.34%-6.77M
-52.42%-5.87M
-25.71%-5.01M
-83.47%-6.31M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-11.52%-26.73M
50.62%-3.34M
-197.21%-17.46M
55.01%-2.25M
41.86%-3.67M
-61.53%-23.96M
-90.34%-6.77M
-52.42%-5.87M
-25.71%-5.01M
-83.47%-6.31M
Basic earnings per share
69.33%-0.46
0
40.54%-0.22
87.10%-0.04
42.50%-0.23
-61.29%-1.5
-90.91%-0.42
-54.17%-0.37
-24.00%-0.31
-81.82%-0.4
Diluted earnings per share
69.33%-0.46
0
40.54%-0.22
87.10%-0.04
42.50%-0.23
-61.29%-1.5
-90.91%-0.42
-54.17%-0.37
-24.00%-0.31
-81.82%-0.4
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 19.35%29.92M-37.83%4.31M202.59%18.7M-41.64%3.09M-42.65%3.82M68.49%25.07M78.58%6.93M52.68%6.18M50.87%5.29M93.63%6.67M
Selling and administrative expenses -0.92%7.22M9.85%1.79M10.67%1.88M-6.96%1.7M-13.21%1.85M-6.42%7.29M-6.11%1.63M-13.97%1.7M-7.99%1.83M1.93%2.13M
-General and administrative expense -0.92%7.22M9.85%1.79M10.67%1.88M-6.96%1.7M-13.21%1.85M-6.42%7.29M-6.11%1.63M-13.97%1.7M-7.99%1.83M1.93%2.13M
Research and development costs 27.66%22.7M-52.50%2.52M275.13%16.83M-59.99%1.38M-56.49%1.97M150.77%17.78M147.19%5.3M115.89%4.49M128.11%3.46M235.53%4.53M
Operating profit -19.35%-29.92M37.83%-4.31M-202.59%-18.7M41.64%-3.09M42.65%-3.82M-68.49%-25.07M-78.58%-6.93M-52.68%-6.18M-50.87%-5.29M-93.63%-6.67M
Net non-operating interest income expense 174.94%3.2M329.00%964.04K328.21%1.24M186.47%840.15K-57.15%152.35K112.69%1.16M-31.46%224.72K51.08%290.44K1,277.13%293.27K5,963.13%355.54K
Non-operating interest income 174.94%3.2M329.00%964.04K328.21%1.24M186.47%840.15K-57.15%152.35K112.69%1.16M-31.46%224.72K51.08%290.44K1,277.13%293.27K5,963.13%355.54K
Other net income (expense) 97.43%-1.43K105.66%3.48K-114.00%-2.15K50.05%-6.11K24.74%3.35K88.93%-55.57K-2,568.41%-61.4K903.20%15.37K97.55%-12.23K316.95%2.69K
Other non- operating income (expenses) 97.43%-1.43K105.66%3.48K-114.00%-2.15K50.05%-6.11K24.74%3.35K-2,672.95%-55.57K-2,568.41%-61.4K903.20%15.37K-305,775.00%-12.23K316.95%2.69K
Income before tax -11.52%-26.73M50.62%-3.34M-197.21%-17.46M55.01%-2.25M41.86%-3.67M-61.53%-23.96M-90.34%-6.77M-52.42%-5.87M-25.71%-5.01M-83.47%-6.31M
Income tax
Net income -11.52%-26.73M50.62%-3.34M-197.21%-17.46M55.01%-2.25M41.86%-3.67M-61.53%-23.96M-90.34%-6.77M-52.42%-5.87M-25.71%-5.01M-83.47%-6.31M
Net income continuous Operations -11.52%-26.73M50.62%-3.34M-197.21%-17.46M55.01%-2.25M41.86%-3.67M-61.53%-23.96M-90.34%-6.77M-52.42%-5.87M-25.71%-5.01M-83.47%-6.31M
Minority interest income
Net income attributable to the parent company -11.52%-26.73M50.62%-3.34M-197.21%-17.46M55.01%-2.25M41.86%-3.67M-61.53%-23.96M-90.34%-6.77M-52.42%-5.87M-25.71%-5.01M-83.47%-6.31M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -11.52%-26.73M50.62%-3.34M-197.21%-17.46M55.01%-2.25M41.86%-3.67M-61.53%-23.96M-90.34%-6.77M-52.42%-5.87M-25.71%-5.01M-83.47%-6.31M
Basic earnings per share 69.33%-0.46040.54%-0.2287.10%-0.0442.50%-0.23-61.29%-1.5-90.91%-0.42-54.17%-0.37-24.00%-0.31-81.82%-0.4
Diluted earnings per share 69.33%-0.46040.54%-0.2287.10%-0.0442.50%-0.23-61.29%-1.5-90.91%-0.42-54.17%-0.37-24.00%-0.31-81.82%-0.4
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------

Market Insights

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Unlock Now

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.